TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AAPG

Ascentage Pharma Group International

Healthcare · Biotechnology

14.90$ +0.0% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Ascentage Pharma Group International (AAPG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.6% of the shares are freely tradable; institutional investors hold 0.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 0.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 76.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.02%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 93Mio.

Largest Shareholders

Institutions

Institutions AAPG
Name Stake (%) Shares Change (%) Date
Point72 Asset Management, L.P. 0.02 16,056 -4.0 03/31/2026
Tower Research Capital LLC 0.00 518 +125.2 03/31/2026
Morgan Stanley - Brokerage Accounts 0.00 498 +225.5 03/31/2026
UBS Group AG 0.00 124 -97.1 03/31/2026

Funds

Funds AAPG
Name Stake (%) Shares Change (%) Date
Fidelity Nasdaq Composite Index 0.00 1,558 +331.6 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?